Gender | Age
Item
women who are 18 years of age or older.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Gender | Heart failure Clinical
Item
women with clinical heart failure for > 2 months.
boolean
C0079399 (UMLS CUI [1])
C0018801 (UMLS CUI [2,1])
C0205210 (UMLS CUI [2,2])
Gender | Left ventricular ejection fraction
Item
women with left ventricular ejection fraction > 50% within 2 months of screening.
boolean
C0079399 (UMLS CUI [1])
C0428772 (UMLS CUI [2])
Gender | Symptoms heart failure | New York Heart Association Classification
Item
women with new york heart association class ii or iii heart failure symptoms.
boolean
C0079399 (UMLS CUI [1])
C2735647 (UMLS CUI [2])
C1275491 (UMLS CUI [3])
Brain natriuretic peptide measurement
Item
brain natriuretic peptide > 62 pg/ml within 2 months of screening.
boolean
C1095989 (UMLS CUI [1])
Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
patient on angiotensin converting enzyme inhibitor or angiotensin receptor blocker therapy for at least 1 month.
boolean
C0003015 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
Blood Pressure
Item
blood pressure no more than 150/95.
boolean
C0005823 (UMLS CUI [1])
Able to walk Walking distance
Item
patient able to walk more than 50 meters at the time of enrollment.
boolean
C2712089 (UMLS CUI [1,1])
C0429886 (UMLS CUI [1,2])
Informed Consent
Item
signed informed consent.
boolean
C0021430 (UMLS CUI [1])
Spironolactone
Item
current treatment with spironolactone.
boolean
C0037982 (UMLS CUI [1])
Hepatic impairment Severe
Item
severe hepatic impairment.
boolean
C0948807 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Creatinine measurement, serum
Item
creatinine > 2.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
Potassium measurement
Item
potassium > 5.0 meq/l
boolean
C0202194 (UMLS CUI [1])
intolerance to Spironolactone
Item
intolerance to spironolactone in the past.
boolean
C1744706 (UMLS CUI [1,1])
C0037982 (UMLS CUI [1,2])
Heart valve disease Significant | Disorder of pericardium | Severe chronic lung disease | Cor pulmonale
Item
significant valvular heart disease, pericardial disease, or severe chronic lung disease with cor pulmonale.
boolean
C0018824 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0265122 (UMLS CUI [2])
C3278799 (UMLS CUI [3])
C0034072 (UMLS CUI [4])
Angina, Unstable | Myocardial Infarction
Item
unstable angina or myocardial infarction within the past 4 weeks.
boolean
C0002965 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
Peripheral Vascular Disease Severe Limiting Walking distance | Physical Condition Limiting Walking distance
Item
severe peripheral vascular disease or other physical conditions that would limit the walking distance.
boolean
C0085096 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0429886 (UMLS CUI [1,4])
C3714565 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0429886 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
pregnant or lactating females.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status
Item
participation in any other drug trial within 30 days prior to randomization.
boolean
C2348568 (UMLS CUI [1])
Informed Consent Unable
Item
inability to provide informed consent.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])